#JPM23: When will the IPO win­dow open? What terms are star­tups get­ting? Here's what to ex­pect from cap­i­tal mar­kets this year

Ex­ec­u­tive Ed­i­tor Drew Arm­strong sat down with Bay­er’s busi­ness de­vel­op­ment leader Mar­i­anne De Backer, PwC’s phar­ma deals chief Roel Van den Akker, and Sofinno­va In­vest­ments …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.